Niagen Bioscience Inc (NASDAQ:NAGE – Get Free Report) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $10.98 and last traded at $10.85, with a volume of 189429 shares. The stock had previously closed at $10.95.
Niagen Bioscience Stock Performance
The firm has a 50 day moving average price of $7.59. The company has a market cap of $856.23 million, a P/E ratio of 63.94 and a beta of 1.94.
About Niagen Bioscience
Niagen Bioscience, Inc is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen.
Further Reading
- Five stocks we like better than Niagen Bioscience
- What Are Dividend Contenders? Investing in Dividend Contenders
- What Ray Dalio’s Latest Moves Tell Investors
- 3 Warren Buffett Stocks to Buy Now
- Amazon: Why May Is the Last Month to Get the Stock at a Discount
- What is a Stock Market Index and How Do You Use Them?
- Qualcomm: This Week Could Make or Break the Rally
Receive News & Ratings for Niagen Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Niagen Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
